Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$238.00K$238.00Kderived+59.7% vs Q4 2024 Net Income-$5.78M-$5.78MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$218,000+58.0% Operating Incomederived-$9,861,000N/M Operating Cash Flowderived-$1,512,000N/M Free Cash Flowderived-$1,512,000N/M Margins · derivedGross margin91.6%−1.0 pt vs Q4 2024
Operating margin-4143.3%−2095.6 pt vs Q4 2024
Net margin-2427.7%+1349.5 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end